ArticleActa pharmacologica Sinica2026

Tectorigenin alleviates HFpEF by targeting the EGFR-EGR2-Acot1 axis to improve myocardial lipid metabolism.

Li-Guo Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.